Inovio Pharmaceuticals In... (INO)
NASDAQ: INO
· Real-Time Price · USD
1.86
0.24 (14.81%)
At close: Aug 15, 2025, 3:59 PM
1.89
1.61%
After-hours: Aug 15, 2025, 07:53 PM EDT
Inovio Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -23.52B | -19.69M | -19.38M | -87.81B | -32.24M | -30.47M | -25M | -33.93M | -35.53M | -40.65M | -54.46M | -37.78M | -108.5M | -79.07M | -106.95M | -60.17M | -82.14M | -54.4M |
Depreciation & Amortization | 741.67M | 743.45K | 775.83K | 765.86K | 828.63K | 759.73K | 175.23K | 1.03M | 1.14M | 1.15M | 1.35M | 1.36M | 1.41M | 1.38M | 2.24M | 860.07K | 831K | 797.47K |
Stock-Based Compensation | 834.79M | 1.4M | 1.32M | 5.28B | 1.51M | 2.53M | 2.27M | 2.08M | 2.92M | 3.81M | 3.27M | 3.23M | 8.34M | 7.71M | 5.47M | 5.62M | 5.65M | 9.6M |
Other Working Capital | n/a | -501.06K | -2.37M | -542.74M | 201.2K | 2.45M | -6.5M | -741.11K | -712.38K | 35.51M | 9.29M | -7.15M | -20.01M | 8.8M | -666.09K | -620.42K | -452.13K | -630.6K |
Other Non-Cash Items | 1.13B | -26.85B | -1.64M | 82.51B | -91.74K | -724K | -1.57M | 9.09M | 313.49K | -2.45M | -3.44M | 2.35M | 5.02M | 7.76M | -382.75K | 238.06K | 756.32K | 247.01K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -32.05K | n/a | 1.09M | n/a | 4.03M | n/a | n/a | n/a | 2.64M | 1.66M | -578.71K | 1.95M |
Change in Working Capital | n/a | -4.77M | -731.05K | -2.86M | 1.78M | -851.25K | -2.11M | -7.38M | -2.24M | 1.48M | 12.91M | -36.63M | 43.21M | 344.2K | 59.08M | 5.3M | -2.97M | -11.05M |
Operating Cash Flow | -20.81B | -26.87B | -19.66M | -27.44M | -28.21M | -28.76M | -26.28M | -29.11M | -32.31M | -36.66M | -36.34M | -67.47M | -50.53M | -61.88M | -37.89M | -46.49M | -78.46M | -52.87M |
Capital Expenditures | n/a | n/a | n/a | 487.83K | -452.25K | -35.58K | 320.9K | n/a | -23.91K | -296.98K | -165.11K | -86.83K | -717.21K | 2M | -643.66K | -168.61K | -207.91K | -210.82K |
Cash Acquisitions | n/a | n/a | 59.32K | n/a | n/a | n/a | n/a | n/a | -53.93M | 6.07M | 2M | -44.64M | 9.59M | -2M | 1,435.8B | n/a | n/a | 210.82K |
Purchase of Investments | -4.95B | n/a | n/a | -54.11B | -19.61M | -9.75M | -29.22M | -67.51M | -26.31M | -80.43M | -44.98M | -64.17M | -39.65M | -99.72M | -40.49M | -607.85K | -32.45M | -275.41M |
Sales Maturities Of Investments | 10.97B | 8.1M | 34.59M | 125.25B | 30.03M | 55.17M | 49.02M | 62.01M | 80.24M | 93.66M | 99.14M | 108.82M | 30.07M | 123.06M | 34.64M | 56.73M | 82.96M | 504.46K |
Other Investing Acitivies | -738.43M | -59.8M | n/a | -71.12B | n/a | n/a | -172.63K | n/a | 53.93M | 19.3M | -2M | 44.64M | -9.59M | -2M | -1,435.8B | 56.13M | 50.51M | -210.82K |
Investing Cash Flow | 5.28B | -51.75M | 34.64M | 14.08M | 9.97M | 45.38M | 19.94M | -5.49M | 53.91M | 19M | 54M | 44.56M | -10.3M | 21.33M | -6.49M | 55.96M | 50.31M | -275.12M |
Debt Repayment | n/a | n/a | 16.41M | n/a | n/a | -16.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -424.7K | n/a | n/a | n/a | n/a | n/a | n/a | -80.38K | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -34.78M | -74.22K | -351.2K | -6.42K | 15.97M | -174.25K | n/a | -9.65K | -32.29K | -424.7K | n/a | 45.6K | -217.69K | -942.52K | 258.54K | -440.78K | 3.44M | -1.2M |
Financial Cash Flow | -34.78M | 1.03M | 29.15M | 660.65K | 33.03M | -11.36M | 1.84M | 698.63K | 2.88M | -424.7K | 6.67M | 3.81M | 42.94M | 28.42M | 47.59M | -440.78K | 3.44M | 160.9M |
Net Cash Flow | -15.56B | -25.9B | 44.13M | -12.7M | 14.79M | 5.29M | -4.49M | -33.91M | 24.47M | -18.09M | 24.34M | -19.11M | -17.91M | -12.13M | 3.2M | 9.02M | -108.34M | -167.09M |
Free Cash Flow | -20.81B | -26.87B | -19.66M | -84.36B | -28.66M | -28.8M | -25.95M | -36.84M | -32.34M | -36.96M | -36.51M | -67.55M | -51.25M | -59.88M | -38.53M | -46.66M | -78.67M | -53.08M |